New genetic mutation could signal start of malaria drug resistance in Africa
2015-04-17
(Press-News.org) Early indicators of the malaria parasite in Africa developing resistance to the most effective drug available have been confirmed, according to new research published in Antimicrobial Agents and Chemotherapy.
Researchers at the London School of Hygiene & Tropical Medicine found Plasmodium falciparum malaria parasites with a mutation to the gene Ap2mu were less sensitive to the antimalarial drug artemisinin.
A study in 2013, also led by the School, suggested an initial link between a mutation in the ap2mu gene and low levels of malaria parasites remaining in the blood of Kenyan children after they had been treated.[1] However, further research was needed to confirm if these genetic characteristics represented an early step towards resistance.
In the new study, researchers genetically altered the malaria parasite in the laboratory to mutate ap2mu in the same way that had been observed in Kenya. They found the altered parasite was significantly less susceptible, requiring 32% more drug to be killed by artemisinin. The genetically altered parasite was also 42.4% less susceptible to the traditional antimalarial drug, quinine.
Earlier this year a different research group discovered mutations in the gene kelch13 which were linked to reduced susceptibility to artemisinin combination treatment in South East Asia.[2] Historically, resistance to antimalarial medicines has emerged in South East Asia and then spread to Africa. But these new findings suggest a different route to drug resistance may be developing independently in Africa.
Lead researcher Dr Colin Sutherland, Reader in Parasitology at the London School of Hygiene & Tropical Medicine, said: "Our findings could be a sign of much worse things to come for malaria in Africa. The malaria parasite is constantly evolving to evade our control efforts. We've already moved away from using quinine to treat cases as the malaria parasite has become more resistant to it, but if further drug resistance were to develop against our most valuable malaria drug, artemisinin, we would be facing a grave situation.
"We now know that the gene ap2mu is an important factor in determining how well our drugs kill malaria parasites. We will be conducting laboratory and field studies to more accurately measure the impact of mutations in the ap2mu gene. We hope our findings will help understand resistance of malaria to drugs, and potentially be an important tool for monitoring malaria treatment in the future."
The World Health Organization estimates more than half a million people die from malaria every year, mostly children under five. Plasmodium falciparum is the most deadly form of the malaria parasite.
INFORMATION:
- Gisela Henriques, Donelly A van Schalkwyk, Rebekah Burrow, David C. Warhurst, Eloise Thompson, David A. Baker, David A. Fidock, Rachel Hallett, Christian Flueck, Colin J. Sutherland. The mu-subunit of Plasmodium falciparum clathrin-associated adaptor protein 2 modulates in vitro parasite response to artemisinin and quinine. Antimicrobial Agents and Chemotherapy. DOI: 10.1128/AAC.04067-14
[1] Beshir, Sutherland et al. Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence. The Journal of infectious diseases. DOI: 10.1093/infdis/jit431
[2] Miotto et al. Genetic architecture of artemisinin resistant Plasmodium falciparum. Nature Genetics. DOI: 10.1038/ng.3189
About the London School of Hygiene & Tropical Medicine
The London School of Hygiene & Tropical Medicine is a world-leading centre for research and postgraduate education in public and global health, with 3,900 students and more than 1,000 staff working in over 100 countries. The School is one of the highest-rated research institutions in the UK, and was recently cited as the world's leading research-focused graduate school. Our mission is to improve health and health equity in the UK and worldwide; working in partnership to achieve excellence in public and global health research, education and translation of knowledge into policy and practice. http://www.lshtm.ac.uk
ELSE PRESS RELEASES FROM THIS DATE:
2015-04-17
COLUMBUS, Ohio - Previous research published by researchers at The Ohio State University Wexner Medical Center and three other institutions showed that when children with attention-deficit/hyperactivity disorder (ADHD) and serious physical aggression were prescribed both a stimulant and an antipsychotic drug, along with teaching parents behavior management techniques, they had a reduction of aggressive and serious disruptive behavior.
Now, L. Eugene Arnold and Michael Aman, professors emeritus at the Nisonger Center at Ohio State's Wexner Medical Center, and their colleagues ...
2015-04-17
RICHMOND, Va. (April 17, 2015) -- In a recent study, Virginia Commonwealth University School of Medicine researchers predicted which cirrhosis patients would suffer inflammations and require hospitalization by analyzing their saliva, revealing a new target for research into a disease that accounts for more than 30,000 deaths in the United States each year.
The findings could trigger a change in the way researchers study chronic liver disease and associated microbiota, the network of tiny organisms in the human body such as bacteria and fungi that can either bolster an ...
2015-04-17
This news release is available in German.
Bonn, April 16 /Tokyo, April 17, 2015 - An international team of researchers at German Center for Neurodegenerative Diseases (DZNE) and Tokyo Institute of Technology (Tokyo Tech) have revealed in a collaborative study - published today in NEURON, that neurons in the eye change on the molecular level when they are exposed to prolonged light. The researchers could identify that a feedback signalling mechanism is responsible for these changes. The innate neuronal property might be utilized to protect neurons from degeneration ...
2015-04-17
By combining two highly innovative experimental techniques, scientists at the University of Illinois at Urbana-Champaign have for the first time simultaneously observed the structure and the correlated function of specific proteins critical in the repair of DNA, providing definitive answers to some highly debated questions, and opening up new avenues of inquiry and exciting new possibilities for biological engineering.
Scientists who study biological systems at the molecular level have over the years looked to the structure of protein molecules--how the atoms are organized--to ...
2015-04-17
In anticipation of the forthcoming 2015 White House Conference on Aging (WHCoA), The Gerontological Society of America (GSA) has produced a special issue of The Gerontologist that outlines a vision for older adults' economic and retirement security, health, caregiving, and social well-being for the next decade and beyond. And because this year also marks the 50th anniversary of Medicare, Medicaid, and the Older Americans Act, as well as the 80th anniversary of Social Security, articles within the issue also explore ways to safeguard the continuing success of these programs.
The ...
2015-04-17
CAMBRIDGE, MA -- Many years of research have shown that for students from lower-income families, standardized test scores and other measures of academic success tend to lag behind those of wealthier students.
A new study led by researchers at MIT and Harvard University offers another dimension to this so-called "achievement gap": After imaging the brains of high- and low-income students, they found that the higher-income students had thicker brain cortex in areas associated with visual perception and knowledge accumulation. Furthermore, these differences also correlated ...
2015-04-17
Geneva, Switzerland, 17 April 2015 -- Cancer DNA circulating in the bloodstream of lung cancer patients can provide doctors with vital mutation information that can help optimise treatment when tumour tissue is not available, an international group of researchers has reported at the European Lung Cancer Conference (ELCC) in Geneva, Switzerland.
The results have important implications for the use of cancer therapies that target specific cancer mutations, explains Dr Martin Reck from the Department of Thoracic Oncology at Lung Clinic Grosshansdorf, Germany, who presented ...
2015-04-17
Geneva, Switzerland, 17 April 2015 -- Almost one in four patients (24%) with advanced lung cancer in Europe, Asia and the US are not receiving EGFR test results before being started on treatment, researchers report at the European Lung Cancer Conference.
Medical Oncologist James Spicer from King's College London at Guy's Hospital, London, and colleagues studied how widely hospitals had implemented testing for mutations in the epidermal growth factor receptor gene among lung cancer patients.
Targeted therapies can more effectively treat cancers that are known to carry ...
2015-04-17
Recent research published in The Diabetes Educator by Dr. Shiela Strauss, associate professor of nursing and co-director of the Statistics and Data Management Core for NYU's Colleges of Nursing and Dentistry, along with a team of NYU researchers, reveals differing perceptions among adult populations at-risk for diabetes that may offer new approaches to diabetes education and prevention.
"We found that there are differences in the perceptions of those who are at risk for diabetes that depend on the specific characteristics that place them at risk," said Strauss.
Illness ...
2015-04-17
A team from Disney Research and Carnegie Mellon University have devised a 3-D printer that layers together laser-cut sheets of fabric to form soft, squeezable objects such as bunnies, doll clothing and phone cases. These objects can have complex geometries and incorporate circuitry that makes them interactive.
"Today's 3-D printers can easily create custom metal, plastic, and rubber objects," said Jim McCann, associate research scientist at Disney Research Pittsburgh. "But soft fabric objects, like plush toys, are still fabricated by hand. Layered fabric printing is one ...
LAST 30 PRESS RELEASES:
[Press-News.org] New genetic mutation could signal start of malaria drug resistance in Africa
